العربية
中国
Français
Deutsch
Ελληνική
हिन्दी
Italiano
日本語
Português
Русский
Español
Title:
Neupro Patches Recalled
Description:
Schwarz Pharma recalled Neupro (rotigotine) transdermal patches at the end of April 2008. These patches are used to treat early stage Parkinson's disease. The problem is that rotigotine, the active ingredient, may crystallize in the patch. If that happens, less drug is available to be absorbed through the skin and so the efficacy of the products may vary. The crystallized drug may cause a patch to have snowflake-like patterns. The more snowflakes, the greater the chance that the patch won't work properly. Because of this, new patients should not be started on Neupro. Patients already using the patch should be slowly titrated off it, and started on an alternative treatment as needed. Patients should not abruptly discontinue treatment with Neupro. The down-titration should proceed according to guidelines in the labeling, using patches that are unaffected or minimally affected by the crystallization. Patients should be told to look at their patches and only use those that have a minimal amount of crystals. (See link below for picture.) For more information, contact the company at 1-800-477-7877 (option 9).
Author:
LawsuitGuru
Tags:
Drug, Recall, Neupro, Transdermal, Patch, FDA, Patient, Safety, Parkinson's, Disease,
Neupro Patches Recalled
Description:
Schwarz Pharma recalled Neupro (rotigotine) transdermal patches at the end of April 2008. These patches are used to treat early stage Parkinson's disease. The problem is that rotigotine, the active ingredient, may crystallize in the patch. If that happens, less drug is available to be absorbed through the skin and so the efficacy of the products may vary. The crystallized drug may cause a patch to have snowflake-like patterns. The more snowflakes, the greater the chance that the patch won't work properly. Because of this, new patients should not be started on Neupro. Patients already using the patch should be slowly titrated off it, and started on an alternative treatment as needed. Patients should not abruptly discontinue treatment with Neupro. The down-titration should proceed according to guidelines in the labeling, using patches that are unaffected or minimally affected by the crystallization. Patients should be told to look at their patches and only use those that have a minimal amount of crystals. (See link below for picture.) For more information, contact the company at 1-800-477-7877 (option 9).
Author:
LawsuitGuru
Tags:
Drug, Recall, Neupro, Transdermal, Patch, FDA, Patient, Safety, Parkinson's, Disease,
Popular searches: Cuba, Scuba Diving, Skydiving, Dubai, Niagara Falls, Rainforest, Surfing, Snowboarding, Sandboarding, Pyramids, Everest, Stonehenge, Bear Grylls
Related Videos:
 | Neupro Patches Recalled Schwarz Pharma recalled Neupro (rotigotine) transdermal patches at the end of April 2008. These patches are used to treat early stage Parkinson's disease. The problem is that rotigotine, the active ingredient, may crystallize in the patch. If that happens, less drug is available to be absorbed through the skin and so the efficacy of the products may vary. The crystallized drug may cause a patch to have snowflake-like patterns. The more snowflakes, the greater the chance that the patch won't ... |
 | New Data on Thromboembolic Events with Ortho Evra Contracept The prescribing information for the Ortho Evra Contraceptive Transdermal Patch is being updated with results of a new study on the risk of venous thromboembolism. This study found that women aged 15-44 who used the birth control patch were at higher risk of developing venous thromboembolism than women using birth control pills. These findings support an earlier study that also concluded that women in this group were at higher risk of venous thromboembolism. Another earlier study found that ... |
 | FDA Studying Potential Safety Issues with Several Drugs FDA has informed the health care community about ongoing safety reviews of several drugs. FDA is doing this as part of its commitment to inform health care professionals and the public about its ongoing drug safety reviews. Because this information is preliminary and there is scientific uncertainty, FDA is not taking regulatory action at this point, and is not advising health care professionals to stop using the drugs. FDA is continuing to evaluate the safety of these products, and will ... |
 | Parkinson's Disease patient using eDiary Here's a patient who is severely impaired by Parkinson's Disease talking about her experience using an ediary. Recorded 2003. www.invivodata.com ...................................... |
 | MDTV: Deep Brain Stimulation in Parkinson's Disease Dr. Dee Silver explains the innovative technique of deep brain stimulation as a treatment for certain candidates suffering from Parkinson's Disease. Series: "MDTV (Medical Doctor Television) " [7/2006] [Health and Medicine] [Show ID: 11828] |
 | Mayo Clinic Research may open the door for Parkinson's Treatment Dr. Demetrius Maraganore and Dr. Matthew Farrer discuss research findings on a treatment for Parkinson's Disease. |
 | Lynda diagnosed with Parkinson's at 34 Lynda talks about life with Parkinson's. |
 | Still Life: The Search for a Parkinson's Cure Reporter Dave Iverson begins a search for a Parkinson's cure in the first of many segments that will eventually culminate in a PBS documentary. A production of Kikim Media. |
 | Hitler Reloaded 4/9 - Erste Ethno-Pille auf dem Markt Es wird offen gelegt, daß die US-Wissenschaft es offensichtlich geschafft hat, "ethische Unterschiede"(= Rassenmerkmale!) in der DNS fest zu machen,bzw. nachzuweisen! Daraufhin entwickelte "man" natürlich auch sogleich Wirkstoffkombinationen, welche NUR DANN die gewünschten Effekte hervorbringen, wenn die "angezielte DNS-Sequenz" vorhanden ist. So wird bspw. gezeigt, daß "sie" schon heute ein Mittel haben, das explizit auf Schwarz-Afrikaner zugeschnitten ist, und so also auch nur bei diesen ... |
 | Kill Billy - Trailer - Por NeuproLvL Existe Kill Bill, y también existe Kill Billy, creado por mí y dos amigos, aquí les dejo el trailer que hicimos para un trabajo. En este vídeo han colaborado: David Jurado Muñoz José Sánchez Martínez Juan Javier Sánchez Vega Recomiendo que veáis el vídeo en HQ. Se prohibe distribuir este vídeo si no se muestran los créditos, los cuales NO deben ser editados ni eliminados, lo mismo se atribuye al vídeo completamente, este trabajo está protegido. |
Popular searches: Cuba, Scuba Diving, Skydiving, Dubai, Niagara Falls, Rainforest, Surfing, Snowboarding, Sandboarding, Pyramids, Everest, Stonehenge, Bear Grylls
